Weis Victoria G, Petersen Christine P, Weis Jared A, Meyer Anne R, Choi Eunyoung, Mills Jason C, Goldenring James R
Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee; and.
Am J Physiol Gastrointest Liver Physiol. 2017 Jan 1;312(1):G67-G76. doi: 10.1152/ajpgi.00326.2016. Epub 2016 Nov 23.
The plasticity of gastric chief cells is exemplified by their ability to transdifferentiate into spasmolytic polypeptide-expressing metaplasia (SPEM) after parietal cell loss. We sought to determine if chief cell maturity is a limiting factor in the capacity to transdifferentiate. Mist1 mice, previously shown to form only immature chief cells, were treated with DMP-777 or L635 to study the capability of these immature chief cells to transdifferentiate into a proliferative metaplastic lineage after acute parietal cell loss. Mist1 mice treated with DMP-777 showed fewer chief cell to SPEM transitions. Mist1 mice treated with L635 demonstrated significantly fewer proliferative SPEM cells compared with control mice. Thus immature chief cells were unable to transdifferentiate efficiently into SPEM after acute parietal cell loss. To determine whether chief cell age affects transdifferentiation into SPEM, we used tamoxifen to induce YFP expression in chief cells of Mist1;Rosa mice and subsequently treated the cells with L635 to induce SPEM at 1 to 3.5 mo after tamoxifen treatment. After L635 treatment to induce acute parietal cell loss, 43% of all YFP-positive cells at 1 mo posttamoxifen were SPEM cells, of which 44% of these YFP-positive SPEM cells were proliferative. By 2 mo after tamoxifen induction, only 24% of marked SPEM cells were proliferating. However, by 3.5 mo after tamoxifen induction, only 12% of marked chief cells transdifferentiated into SPEM and none were proliferative. Thus, as chief cells age, they lose their ability to transdifferentiate into SPEM and proliferate. Therefore, both functional maturation and age limit chief cell plasticity.
NEW & NOTEWORTHY: Previous investigations have indicated that spasmolytic polypeptide-expressing metaplasia (SPEM) in the stomach arises from transdifferentiation of chief cells. Nevertheless, the intrinsic properties of chief cells that influence transdifferentiation have been largely unknown. We now report that the ability to transdifferentiate into SPEM is impaired in chief cells that lack full functional maturation, and as chief cells age, they lose their ability to transdifferentiate. Thus chief cell plasticity is dependent on both cell age and maturation.
胃主细胞的可塑性表现为在壁细胞缺失后它们能够转分化为表达解痉多肽化生(SPEM)细胞。我们试图确定主细胞成熟度是否是转分化能力的限制因素。先前已证明只能形成未成熟主细胞的Mist1小鼠,用DMP - 777或L635处理,以研究这些未成熟主细胞在急性壁细胞缺失后转分化为增殖性化生谱系的能力。用DMP - 777处理的Mist1小鼠显示主细胞向SPEM的转变较少。与对照小鼠相比,用L635处理的Mist1小鼠显示增殖性SPEM细胞明显较少。因此,急性壁细胞缺失后,未成熟主细胞不能有效地转分化为SPEM。为了确定主细胞年龄是否影响向SPEM的转分化,我们使用他莫昔芬在Mist1;Rosa小鼠的主细胞中诱导YFP表达,随后在他莫昔芬处理后1至3.5个月用L635处理细胞以诱导SPEM。在L635处理诱导急性壁细胞缺失后,他莫昔芬处理后1个月时,所有YFP阳性细胞中有43%是SPEM细胞,其中这些YFP阳性SPEM细胞中有44%是增殖性的。在他莫昔芬诱导后2个月时,只有24%的标记SPEM细胞在增殖。然而,在他莫昔芬诱导后3.5个月时,只有12%的标记主细胞转分化为SPEM,且无增殖性细胞。因此,随着主细胞老化,它们失去了转分化为SPEM并增殖的能力。所以,功能成熟和年龄都限制了主细胞的可塑性。
先前的研究表明,胃中表达解痉多肽化生(SPEM)源于主细胞的转分化。然而,影响转分化的主细胞内在特性在很大程度上尚不清楚。我们现在报告,缺乏完全功能成熟的主细胞向SPEM转分化的能力受损,并且随着主细胞老化,它们失去了转分化的能力。因此,主细胞的可塑性取决于细胞年龄和成熟度。